🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Vaxcyte, Inc.

PCVX Healthcare
$58.38 $-0.12 (-0.21%)
Market Cap: $8.4 B
Gurus Holding
4
Popularity Rank
#2336
% of Shares Held
1.11%
Net Activity (Q4 2025)
-$24.79 M

Guru Ownership Trend

Guru Analysis for Vaxcyte, Inc. (PCVX)

Vaxcyte, Inc. (PCVX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $93.16 M.

Top institutional holders include Lee Ainslie and Steven Cohen.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $24.79 M net outflow during the quarter.

Recent activity highlights Cliff Asness who opened a new position. Conversely, Steven Cohen reduced exposure by 76.8%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$3.66 M
Total Buy Value
New Buys 1
Additions 1
-$28.46 M
Total Sell Value
Reductions 2
Sold Out 2

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
4
Net Buyers
2

FAQs for Vaxcyte, Inc. (PCVX)

Major holders include Lee Ainslie ($62.48 M), Steven Cohen ($7.46 M), Renaissance Technologies (RenTech) ($3.01 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.6 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $24.79 M, with 2 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited PCVX. The total reported sell value was $28.46 M.

Yes, 1 managers opened new positions in PCVX, and 1 increased their existing holdings. The total reported buy value was $3.66 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.67% Add 5.0% 1,354,237 $62.48 M Q4 2025
0.01% Reduce -76.8% 161,614 $7.46 M Q4 2025
0.00% Reduce -19.0% 65,211 $3.01 M Q4 2025
0.00% New Buy 14,762 $681,119 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form